Xin Wang, MD, MSCE
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
Conditions I Treat
- Leukemia
- Acute lymphocytic leukemia (ALL)
- Acute myeloid leukemia (AML)
My Specialties
- Clinical trials
Get to Know Me
I am a medical oncologist and hematologist who specializes in caring for people with acute and chronic leukemia, myelodysplastic syndromes and myeloproliferative neoplasms. I see patients at the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center. I make every effort to provide my patients and their families with compassionate care that best suits their individual goals and needs.
As an oncologist, I often meet my patients and their loved ones at a very vulnerable time of their lives. I value a strong partnership and open communication between our care team and our patients and families. With my training and background, I also recognize the importance of cultural awareness in cancer care, which can help us better understand our patients and lead to improved outcomes and reduce disparities in care.
I want my patients to know that I will always spend time discussing their diagnosis and explaining the different treatments and supportive care options available. I am committed to getting to know them and their background, and being available to address their concerns. My goal is to make my patients feel informed, empowered, and supported throughout their care journey.
As a researcher, I am interested in using real-world data and advanced epidemiological methods to answer challenging, relevant clinical questions and to inform future studies and drug development. I have a strong interest in understanding the inequalities in modern cancer care delivery and integrating disparity research into clinical trial design. I also help design and conduct clinical trials that investigate new treatment options for patients with acute myeloid leukemia and myelodysplastic syndrome. Together with a team of expert clinicians, scientists, and support professionals at MSK, we aim to improve the care and outcomes of patients with leukemias and other blood cancers.
I’m a leukemia specialist, which is a doctor with special training in diagnosing and treating leukemia (loo-KEE-mee-uh). This cancer starts in tissue that forms blood, such as bone marrow.
- Assistant Attending Physician
Conditions I Treat
- Leukemia
- Acute lymphocytic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Acute promyelocytic leukemia (APL)
- Chronic lymphocytic leukemia (CLL)
- Chronic myeloid leukemia (CML)
- Myeloproliferative neoplasms (MPN)/Myeloproliferative disorders
- Hairy cell leukemia (HCL)
- Systemic mastocytosis
- Myelodysplastic syndrome (MDS)
- Blood, bone marrow, and hematologic cancers and conditions
My Specialties
- Clinical trials
Education
- MSCE, University of Pennsylvania
- MD, Xiangya School of Medicine, China
Residencies
- Internal Medicine, University of Massachusetts
Fellowships
- Hematology and Oncology, University of Pennsylvania
Board Certifications
- Internal Medicine
Awards and Honors
- Stanley Bradley Award for Clinical Science Research, University of Pennsylvania (2024)
- Abstract Achievement Award, American Society of Hematology (2023)
- F32 Individual Postdoctoral Fellowship Award, National Institutes of Health (2023-2025)
- Hematology-Oncology Health Equity Pilot Grant, University of Pennsylvania (2022)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, EPO PPO, POS, Transplant
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
POS, EPO, HMO
In Network Coverage Type
State Government
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
State Government
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO EPO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
TBD
In Network Coverage Type
PPO, POS, EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO/OAP
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO/EPO
In Network Coverage Type
PPO, EPO
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, POS
In Network Coverage Type
PPO, POS, HMO
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Wang
- A Phase 1 Study of AUTX-703 in People With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- A Phase 1b Study of Eganelisib Alone or With Cytarabine in People With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- A Phase 2 Study Comparing Daunorubicin/Cytarabine, Daunorubicin/Cytarabine/Venetoclax, and Venetoclax/Azacitidine in Young Adults With Intermediate-Risk Acute Myeloid Leukemia
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Wang’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Xin Wang discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.